Financial Toxicity in Patients With Early-stage Breast Cancer

Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for early-stage breast cancer patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.

NCT Number	NCT07354165
Lead Sponsor	National Cancer Institute, Naples
Conditions	Breast Cancer
Enrollment	864 participants
Start Date	2025-09-30
Primary Completion	2030-09 (estimated)
Study Completion	2034-09 (estimated)
Updated on ClinicalTrials.gov	2026-01-21